Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement | Revista Española de Cirugía Ortopédica y Traumatología (English Edition)

Statistics

Original article

Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement

Análisis coste-efectividad de apixaban frente a dabigatrán en la prevención de la tromboembolia venosa en pacientes intervenidos de artroplastia total de rodilla o de cadera

J.F. Gómez-Cerezoa, I. Gómez-Arrayásb, C. Suárez-Fernándezc, L. Betegón-Nicolásd, M. de Salas-Cansadoe, C. Rubio-Terrésf,

Corresponding author

crubioterres@healthvalue.org

Corresponding author.

a Servicio de Medicina Interna, Hospital Universitario Infanta Sofía, Madrid, Spain

b Servicio de Traumatología y Cirugía Ortopédica, Hospital Ruber Internacional, Madrid, Spain

c Servicio de Medicina Interna, Hospital Universitario de La Princesa, Madrid, Spain

d Bristol-Myers Squibb España, Madrid, Spain

e Pfizer España, Madrid, Spain

f Health Value, Madrid, Spain

Read

3344

Times
was read the article

1220

Total PDF

2124

Total HTML

Share statistics

Article information

ISSN: 19888856
Original language: English

DOI:10.1016/j.recote.2012.10.005

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 May	10	9	19
2024 April	52	34	86
2024 March	53	10	63
2024 February	33	9	42
2024 January	69	12	81
2023 December	23	10	33
2023 November	15	10	25
2023 October	26	36	62
2023 September	24	13	37
2023 August	21	21	42
2023 July	16	19	35
2023 June	36	17	53
2023 May	46	29	75
2023 April	47	7	54
2023 March	26	12	38
2023 February	18	22	40
2023 January	16	14	30
2022 December	19	11	30
2022 November	14	21	35
2022 October	19	17	36
2022 September	22	30	52
2022 August	18	12	30
2022 July	14	13	27
2022 June	32	14	46
2022 May	20	18	38
2022 April	26	17	43
2022 March	23	19	42
2022 February	24	18	42
2022 January	19	15	34
2021 December	20	10	30
2021 November	21	26	47
2021 October	16	13	29
2021 September	18	15	33
2021 August	26	18	44
2021 July	21	11	32
2021 June	14	15	29
2021 May	17	9	26
2021 April	27	14	41
2021 March	31	14	45
2021 February	12	12	24
2021 January	14	15	29
2020 December	1	0	1
2020 November	0	7	7
2020 October	0	3	3
2020 September	0	8	8
2020 August	0	3	3
2020 July	0	5	5
2020 June	0	2	2
2020 May	0	7	7
2020 April	0	6	6
2020 March	0	5	5
2020 February	0	34	34
2020 January	0	17	17
2019 December	0	17	17
2019 November	0	12	12
2019 October	0	5	5
2019 September	0	6	6
2019 August	0	5	5
2019 July	0	11	11
2019 June	0	21	21
2019 May	0	34	34
2019 April	0	44	44
2019 March	0	3	3
2019 February	0	13	13
2019 January	0	2	2
2018 December	0	19	19
2018 November	0	5	5
2018 October	0	19	19
2018 February	8	0	8
2018 January	14	1	15
2017 December	9	0	9
2017 November	28	0	28
2017 October	20	1	21
2017 September	24	2	26
2017 August	19	3	22
2017 July	26	2	28
2017 June	63	9	72
2017 May	25	2	27
2017 April	18	2	20
2017 March	16	29	45
2017 February	20	12	32
2017 January	16	4	20
2016 December	33	8	41
2016 November	40	8	48
2016 October	60	18	78
2016 September	52	6	58
2016 August	30	2	32
2016 July	14	1	15
2016 June	18	3	21
2016 May	21	15	36
2016 April	20	19	39
2016 March	25	14	39
2016 February	36	12	48
2016 January	9	11	20
2015 December	16	5	21
2015 November	31	3	34
2015 October	22	4	26
2015 September	16	5	21
2015 August	43	7	50
2015 July	42	1	43
2015 June	29	4	33
2015 May	31	2	33
2015 April	31	3	34
2015 March	29	5	34
2015 February	29	0	29
2015 January	31	9	40
2014 December	50	5	55
2014 November	32	8	40
2014 August	2	0	2
2014 July	1	0	1
2014 June	0	1	1
2014 May	2	0	2
2013 June	1	0	1
2013 May	3	0	3

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter